Literature DB >> 18387670

Altered uterine perfusion is involved in fetal outcome of diabetic rats.

S Zabihi1, P Wentzel, U J Eriksson.   

Abstract

Maternal diabetes affects the development of the offspring by altering the uterine environment. We aimed to investigate the extent to which the blood flow (measured as Tissue Perfusion Units; TPU) to implantation sites and the expression of developmentally important genes in the offspring are affected by maternal diabetes. We measured mRNA levels of superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPX), Bcl-2 associated X protein (Bax), B-cell lymphoma protein (Bcl-2), tumor suppressor protein-53 (p53), paired box protein-3 (Pax-3) and vascular endothelial growth factor-A (Vegf-A). Moreover, we studied the effect on uterine blood flow (TPU) and the expression of the genes exerted by embryonic maldevelopment (malformation or resorption). Streptozotocin induced diabetic (D) and non-diabetic (N) pregnant rats were used in the study. Blood flow (TPU) to implantation sites was measured by a laser Doppler flow meter, and gene expression was analyzed by RT-PCR. Maternal diabetes caused increased blood flow (TPU) to implantation sites compared with normal pregnancy. Furthermore, implantation sites of D rats containing malformed offspring showed impaired growth and decreased blood flow (TPU) compared with their littermates at all gestational days. Resorbed offspring from both N and D rats displayed increased blood flow (TPU) compared with their non-resorbed littermates. Moreover, we found that maternal diabetes causes decreased expression of genes involved in the oxidative stress defense system (CuZnSOD in non-malformed D11 embryos, MnSOD at all gestational time points, ECSOD and Gpx-1 at GD11-GD15, CAT and Gpx-2 at GD15), decreased expression of Pax-3 at GD11, and increased expression of Vegf-A at all gestational time points. We conclude that both maternal metabolism and embryonic developmental state affect the blood flow (TPU) to the implantation site. Maternal diabetes causes decreased expression of anti-oxidative enzymes and enhanced angiogenesis in the offspring in rats.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18387670     DOI: 10.1016/j.placenta.2008.02.005

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  12 in total

1.  Altered gene expression and spongiotrophoblast differentiation in placenta from a mouse model of diabetes in pregnancy.

Authors:  J M Salbaum; C Kruger; X Zhang; N Arbour Delahaye; G Pavlinkova; D H Burk; C Kappen
Journal:  Diabetologia       Date:  2011-04-14       Impact factor: 10.122

Review 2.  Diabetic complications in pregnancy: is resveratrol a solution?

Authors:  Chandra K Singh; Ambrish Kumar; Holly A Lavoie; Donald J Dipette; Ugra S Singh
Journal:  Exp Biol Med (Maywood)       Date:  2013-05-29

3.  Placental perfusion in uterine ischemia model as evaluated by dynamic contrast enhanced MRI.

Authors:  Alexander Drobyshevsky; P V Prasad
Journal:  J Magn Reson Imaging       Date:  2015-04-09       Impact factor: 4.813

4.  Resveratrol prevents embryonic oxidative stress and apoptosis associated with diabetic embryopathy and improves glucose and lipid profile of diabetic dam.

Authors:  Chandra K Singh; Ambrish Kumar; David B Hitchcock; Daping Fan; Richard Goodwin; Holly A LaVoie; Prakash Nagarkatti; Donald J DiPette; Ugra S Singh
Journal:  Mol Nutr Food Res       Date:  2011-01-20       Impact factor: 5.914

5.  Diet-induced impaired glucose tolerance and gestational diabetes in the dog.

Authors:  Mary Courtney Moore; Renuka Menon; Katie C Coate; Maureen Gannon; Marta S Smith; Ben Farmer; Phillip E Williams
Journal:  J Appl Physiol (1985)       Date:  2010-11-18

6.  Deficiency of the oxidative stress-responsive kinase p70S6K1 restores autophagy and ameliorates neural tube defects in diabetic embryopathy.

Authors:  Songying Cao; Wei-Bin Shen; E Albert Reece; Peixin Yang
Journal:  Am J Obstet Gynecol       Date:  2020-05-13       Impact factor: 8.661

7.  Maternal diabetes causes developmental delay and death in early-somite mouse embryos.

Authors:  Jing Zhao; Theodorus B M Hakvoort; Jan M Ruijter; Aldo Jongejan; Jan Koster; Sigrid M A Swagemakers; Aleksandar Sokolovic; Wouter H Lamers
Journal:  Sci Rep       Date:  2017-09-15       Impact factor: 4.379

8.  Impact of Metformin and Pioglitazone on Serum Level of Tumor Necrosis Factor-Alpha and Lipid Profiles during Implantation Window in Diabetic Rats.

Authors:  Abbas Bakhteyari; Parvaneh Nikpour; Fatemah Sadat Mostafavi; Nahid Eskandari; Mohammad Matinfar; Sara Soleimani Asl; Roshanak Aboutorabi
Journal:  Int J Fertil Steril       Date:  2019-04-27

9.  Importance of maternal diabetes on the chronological deregulation of the intrauterine development: an experimental study in rat.

Authors:  Marcela Salazar García; Elba Reyes Maldonado; María Cristina Revilla Monsalve; Laura Villavicencio Guzmán; Alfonso Reyes López; Concepción Sánchez-Gómez
Journal:  J Diabetes Res       Date:  2015-02-09       Impact factor: 4.011

10.  Evaluation of Osteopontin Gene Expression in Endometrium of Diabetic Rat Models Treated with Metformin and Pioglitazone.

Authors:  Zeinab Sadat Hosseiny; Parvaneh Nikpour; Abas Bakhtiary; Fatemah Sadat Mostafavi; Mohammad Matinfar; Mehrnaz Jahani; Roshanak Aboutorabi
Journal:  Int J Fertil Steril       Date:  2018-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.